Inventor

LORENZI SILVANA

IT19 patents

⚠️ This page may combine multiple inventors who share the name “LORENZI SILVANA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LORENZI SILVANA

LIFEGROUP SPA

Highly bioadhesive and mucoadhesive compositions containing polyvinyl alcohol, polycarbophil and biopolymer for the treatment of skin conditions and as vehicles for active ingredients

Therapeutic use of mono and bicarboxylic acid amides active at the peripheral cannabinoid receptor

N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin

Trans and cis traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity

Water soluble derivatives of biotin and related therapeutical compositions

Hydroxyamines N-acyl derivatives having scavenger activity and useful in acute and chronic pathologies associated with peroxidation and inflammation phenomena

Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve

N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes

Use of N-acyl derivatives of aminoalcohols in the manufacture of a medicament for practicing neuroprotective action in neuropathological states connected with excitotoxicity

Biotin amides able to control glucidic metabolisms under dysmetabolic conditions and relative therapeutical compositions

FIDIA SPA

Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions

Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same

Pharmaceutical compositions containing hyaluronic acid fractions

Process for preparing salt of hyaluronic acid with a pharmaceutically active substance

Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use

Human nerve growth factor

Therapeutic use of GM1 in severe cerebral ischemic strokes pathologies

Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses

Gangliosides mixture, useful as a therapeutical tool for eliminating painful effects or peripheral neuropathies